Abstract
Background: The impact of on blood pressure (BP) and incidence of diabetes mellitus has not yet been elucidated. Therefore, the present study aimed to systematically discuss the prevalence of DM and hypertension in the published studies during the COVID-19 pandemic between 2019 and 2022 and compare these results with results reported in previous studies. Methodology: This was a comprehensive electronic systematic review that was time and language restricted. The search was conducted depending on different databases including PubMed, Google Scholar, Web of Science, and Cochrane library, for all studies published in the period between 2019 and 2022. Keywords used included COVID-19 OR SARS-CoV-2 OR Coronavirus OR “Corona virus” OR COVID, AND hypertension OR diabetes mellitus OR prevalence OR metabolic disorders AND cardiovascular conditions. The period of the study was chosen based on the fact that COVID-19 started in the beginning of 2019. Results: The primary search results of the current analysis ended in 875 hits which were reduced to 360 studies after removal of the duplicated studies. From those 360 studies, further evaluation for inclusion and exclusion criteria was conducted ending in 346 excluded studies. The reasons for exclusion included because of title and abstract (216 studies), being not relevant to the subject of the study (86 studies), being replies to authors (17 studies), books (2 topics), and being other reviews (26 studies). Finally , we included 13 studies in the qualitative synthesis of the current review. Conclusion: There was no significant increase in the prevalence of diabetes mellitus and hypertension among the general public in different regions of the world during the period of the COVID-19 pandemic compared with previous studies. Keywords: COVID-19, hypertension, diabetes mellitus
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call